Internal Medicine
New WHO Guidance: Corticosteroids for COVID-19
3 Sep, 2020 | 11:20h | UTCCorticosteroids for COVID-19 – World Health Organization
News Release: WHO updates clinical care guidance with corticosteroid recommendations – World Health Organization
Commentaries: The WHO Now Recommends Cheap Steroids As a Life-Saving Treatment for Severe Covid-19 – Gizmodo AND Inexpensive steroids reduce deaths of hospitalized Covid-19 patients, WHO analysis confirms – STAT
Commentary on Twitter
🆕 guideline on use of dexamethasone & other corticosteroids advises:
✅ for oral or intravenous usage in treatment of patients with severe & critical #COVID19
❌ against usage in treatment of non-severe casesMore: https://t.co/eWHzRrYKvO
— World Health Organization (WHO) (@WHO) September 2, 2020
[Preprint] Randomized trial: Tocilizumab does not improve clinical status or mortality in hospitalized patients with COVID-19 pneumonia
3 Sep, 2020 | 11:19h | UTCTocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv
Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic
3 Sep, 2020 | 11:15h | UTCCommentaries: COVID-19 has likely tripled depression rate, study finds – Boston University School of Medicine AND Pandemic’s Emotional Hammer Hits Hard – NPR AND Depression Increases More Than Three-Fold In Wake Of Pandemic, BU Study Finds – CommonHealth
Covid-19: Study found those younger than 40 had an infection fatality ratio (IFR) of 0.01%; those 60 or older had an IFR of 1.71%
3 Sep, 2020 | 11:18h | UTC
Commentary on Twitter
Age, sex, race affect death risk from #COVID-19. @FSPH_IUPUI study found those younger than 40 had fatality rate of 0.01%; those 60 or older 1.71%—2.5 times greater than #flu https://t.co/oT4BCVbVxe. @jblackburn_phd @aaronecarroll pic.twitter.com/wE6Ti0EG6E
— Annals of Int Med (@AnnalsofIM) September 2, 2020
Virus in the blood can predict severe COVID-19
3 Sep, 2020 | 11:11h | UTCVirus in the blood can predict severe COVID-19 – Karolinska Institutet
Original Study: SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study – Clinical Infectious Diseases
COVID-19 can wreck your heart, even if you haven’t had any symptoms
3 Sep, 2020 | 11:06h | UTCCOVID-19 Can Wreck Your Heart, Even if You Haven’t Had Any Symptoms – Scientific American
IDSA Podcast – Managing patients post-COVID-19: From symptoms to lasting complications
3 Sep, 2020 | 11:08h | UTC
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection
3 Sep, 2020 | 11:10h | UTCOriginal Study: Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant – Cell Reports Medicine
23 bus passengers contracted coronavirus from 1 infected person. No one was wearing a mask.
2 Sep, 2020 | 10:09h | UTCOriginal Study: Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China – JAMA Internal Medicine
Commentary on Twitter
Outbreak on a bus in China is offering new evidence about SARSCoV2's airborne spread. A person on a poorly ventilated vehicle infected nearly 2 doz people even tho many weren't sitting nearby. Conclusion: mere breathing can send micro-droplets into the air https://t.co/plxzOrZLAT
— delthia ricks 🔬 (@DelthiaRicks) September 1, 2020
Study: Face shields, masks with valves ineffective against COVID-19 spread
2 Sep, 2020 | 09:55h | UTCFace Shields, Masks with Valves Ineffective Against COVID-19 Spread – American Institute of Physics
Original Study: Visualizing droplet dispersal for face shields and masks with exhalation valves – Physics of Fluids
Opinion: Managing uncertainty in the Covid-19 era
2 Sep, 2020 | 09:49h | UTCManaging uncertainty in the covid-19 era – The BMJ
Commentary on Twitter
https://mobile.twitter.com/fibke/status/1300795813543673857
Meta-analysis: Clinical manifestations, risk factors, and maternal and perinatal outcomes of Covid-19 in pregnancy
2 Sep, 2020 | 09:52h | UTC
ADA Guideline synopsis: Pharmacologic approaches to glycemic treatment of Type 2 Diabetes
2 Sep, 2020 | 09:41h | UTC
#ESCCongress – [Not Published Yet] First randomized trial backs safety of ACE Inhibitors and ARBs in COVID-19 patients
2 Sep, 2020 | 09:48h | UTCNews Release: First randomised trial backs safety of common heart drugs in COVID-19 patients – European Society of Cardiology
Commentary on Twitter
Dr. Renato Lopes presents the BRACE CORONA trial: in patients hospitalized with COVID-19, suspending ACEI/ARB therapy for 30 days did not impact the number of days alive and out of hospital.
Full slide deck: https://t.co/avSK41bGSj#ESCCongress pic.twitter.com/2p0FH9U2RG
— C. Michael Gibson MD (@CMichaelGibson) September 1, 2020
Perspective: Age in the Age of COVID-19
2 Sep, 2020 | 09:45h | UTCAge in the Age of COVID-19 – Think Global Health
#ESCCongress – [Not Published Yet] Randomized trial on transfusion thresholds in anemic heart attack patients
2 Sep, 2020 | 09:42h | UTCNews Release: Trial clarifies use of blood transfusion in anaemic heart attack patients – European Society of Cardiology
Guideline synopsis: The diagnosis and management of hypertension in the primary care setting
2 Sep, 2020 | 09:38h | UTC
Pulmonary hypertension: A brief guide for clinicians
2 Sep, 2020 | 09:34h | UTCPulmonary Hypertension: A Brief Guide for Clinicians – Mayo Clinic Proceedings
Position Paper: Diagnosis and treatment of pulmonary embolism during the COVID-19 pandemic
1 Sep, 2020 | 06:27h | UTC
Anticoagulation in COVID-19: A systematic review, meta-analysis and rapid guidance from the Mayo Clinic
1 Sep, 2020 | 06:26h | UTC
Cases of SARS-CoV-2 reinfection highlight the limitations — and the mysteries — of our immune system
1 Sep, 2020 | 06:18h | UTC
Asthma in COVID-19 hospitalizations: An overestimated risk factor?
1 Sep, 2020 | 06:22h | UTC
Commentary on Twitter
https://twitter.com/holguinf01/status/1300505812473843713
Scientists are reporting several cases of Covid-19 reinfection — but the implications are complicated
1 Sep, 2020 | 06:20h | UTC
Low risk of COVID-19 among patients exposed to infected healthcare workers
1 Sep, 2020 | 06:14h | UTC
Commentary on Twitter
Low risk of COVID-19 among patients exposed to infected healthcare workers | #CID The risk of acquiring #SARSCoV2 from an infected HCW was low in a study that tested patients exposed to 60 HCWs with unrecognized SARS-CoV-2 infection. https://t.co/4hppyoXSLC
— Carlos del Rio (@CarlosdelRio7) September 1, 2020
What Is the predictive value of a single nasopharyngeal SARS-CoV-2 PCR swab test in a patient with COVID-like symptoms and / or significant COVID-19 exposure?
1 Sep, 2020 | 06:12h | UTC
Commentary on Twitter
What Is the Predictive Value of a Single Nasopharyngeal SARS-CoV-2 PCR Swab Test in a Patient with COVID-like Symptoms and / or Significant #COVID19 Exposure?
The PCR-test was found to be 87% sensitive, 97% specific, a PPV of 0.98, and a NPV of 0.80 #ofid https://t.co/MGQdzDsd8k— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 31, 2020